Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP

Last updated on 2024-03-28 History
Report ID 193649
Drug Identification Number 02244475
Brand name DIPYRIDAMOLE INJECTION, USP
Common or Proper name DIPYRIDAMOLE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) DIPYRIDAMOLE
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-07-01
Actual start date 2023-08-23
Estimated end date 2024-06-30
Actual end date
Shortage status Actual shortage
Updated date 2024-03-28
Company comments Please be advised that this product is on 100% allocation.
Health Canada comments
Tier 3 Status Yes
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2024-03-28 French Compare
v21 2024-03-28 English Compare
v20 2024-03-28 English Compare
v19 2024-02-01 French Compare
v18 2024-02-01 English Compare
v17 2024-01-31 French Compare
v16 2024-01-31 English Compare
v15 2023-11-29 French Compare
v14 2023-11-29 English Compare
v13 2023-10-03 French Compare
v12 2023-10-03 English Compare
v11 2023-08-24 English Compare
v10 2023-08-18 French Compare
v9 2023-08-18 English Compare
v8 2023-07-21 French Compare
v7 2023-07-21 English Compare
v6 2023-07-18 English Compare
v5 2023-07-02 English Compare
v4 2023-06-02 French Compare
v3 2023-06-02 English Compare

Showing 1 to 20 of 22